“We write with regard to the government’s review of Canada’s Access to Medicines Regime (CAMR), currently underway, and to share you with some highlights of findings from a recent international consultation our organizations co-hosted to examine CAMR and related issues. . . .
“The full report of the Expert Consultation will follow in due course, but we wish to share with you highlights of the consultation, as a way of further informing and contributing to the government’s review of CAMR.”